Pediatrics and Human Development Professor and Associate Chair for Research André S. Bachmann, PhD has been awarded $461,318.00 by the National Cancer Institute in an R21 to design and characterize novel, natural products-inspired ODC inhibitors with activity in pediatric neuroblastoma. Please join us in congratulating Dr. Bachmann and wishing him and his lab the best in their studies to come.